Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 4AbbVie Inc
03 7Orion Corporation
04 1Strides Pharma Science
05 1ANGENERICO SpA
06 1Abon Pharmaceuticals
07 2Amneal Pharmaceuticals
08 1Apotex Inc
09 1Bahrain Pharma
10 1Cosette Pharma
11 2DOC Generici
12 1Genchain Biotech
13 1Hanlim Pharmaceuticals Inc
14 1Hikma Pharmaceuticals
15 1Kolmar Korea Co., Ltd.
16 3LABORATORI BALDACCI SpA
17 2Laboratori Baldacci
18 6Lisapharma Spa
19 1Nostrum Laboratories
20 1Novell Pharmaceutical Laboratories
21 1Opes Health Care
22 1PD PARTNERS
23 1Padagis
24 1Pharmascience Inc.
25 2S.F.GROUP Srl
26 2SCHARPER SpA
27 2SF Group
28 2Scharper
29 1Sofar Spa
30 1Solfran Laboratories
31 1Solitaire Pharmacia
32 2Teva Pharmaceutical Industries
33 1Vaishali Pharma Ltd
34 1Viatris
35 1Vista Pharmaceuticals
36 1Zydus Lifesciences
01 2Antic-calc Tablet
02 1Chewable Tablets
03 3Gel
04 3Granules For Oral Suspension
05 1Ml
06 1ORAL SUSPENSION
07 1ORAL SUSPENSION IN SACHET
08 1Oral Powder
09 2Potion, suspension
10 3SUSPENSION
11 10SUSPENSION;ORAL
12 2Sachet
13 1Sachets
14 4Sucralfate 1.000Mg 40 Combined Oral Use
15 8Sucralfate 2.000Mg 30 Joined' Oral Use
16 1Sucralfate 20% 200Ml Oral Use
17 3Suspension
18 5TABLET
19 5TABLET;ORAL
20 4Tablet
21 2Tablets
01 1DISCN
02 4Generic
03 5Prescription
04 13RX
05 40Blank
01 2ANTEPSIN
02 1APO-SUCRALFATE - TAB 1G
03 1Almiso Tablet
04 3Andapsin
05 7Antepsin
06 2CARAFATE
07 2DEGASTRIL
08 2Degastril
09 1PMS-SUCRALFATE
10 1Peptovell
11 13SUCRALFATE
12 1SUCRALFATE DOC GENERIC
13 2SUCRALFIN
14 2SUCRAMAL
15 1SUCRAMED
16 1SUCRATES
17 1SULCRATE
18 1SULCRATE SUSPENSION PLUS
19 2Skincol
20 2Sucralfate
21 2Sucralfin
22 2Sucramal
23 1Sucrate
24 2Sucrate Gel
25 1Sucroril
26 1Sufad
27 1TEVA-SUCRALFATE
28 1Ulivotina
29 4Blank
01 1Bahrain
02 5Canada
03 1China
04 3India
05 1Indonesia
06 27Italy
07 1Mexico
08 4Norway
09 2South Korea
10 3Sweden
11 15USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Sucralfin
Dosage Form : Sucralfate 1.000Mg 40 Combined Oral Use
Dosage Strength : 40 CPR 1 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CARAFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1982-01-01
Application Number : 18333
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : ORAL SUSPENSION IN SACHET
Dosage Strength : 1 G / 5 ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2024-05-21
Application Number : 216474
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Sucralfin
Dosage Form : Sucralfate 2.000Mg 30 Joined' Oral Use
Dosage Strength : os grat 30 bust 2 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : SUCRALFIN
Dosage Form : Sachets
Dosage Strength : 2g
Packaging : 30 UNITS 2000 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : SUCRALFIN
Dosage Form : Tablet
Dosage Strength : 1g
Packaging : 40 UNITS 1000 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CARAFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 1993-12-16
Application Number : 19183
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SULCRATE SUSPENSION PLUS
Dosage Form : SUSPENSION
Dosage Strength : 1G/5ML
Packaging :
Approval Date :
Application Number : 2103567
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SULCRATE
Dosage Form : TABLET
Dosage Strength : 1G
Packaging :
Approval Date :
Application Number : 2100622
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : ORAL SUSPENSION
Dosage Strength : 200 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Andapsin
Dosage Form : TABLET
Dosage Strength : 1 G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Antic-calc Tablet
Dosage Strength : 1 g
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Antic-calc Tablet
Dosage Strength : 1 g
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Potion, suspension
Dosage Strength : 200 mg/ml
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Antepsin
Dosage Form : Potion, suspension
Dosage Strength : 200 mg/ml
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2019-12-02
Application Number : 209356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1998-06-08
Application Number : 74415
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date :
Application Number : 211780
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1996-03-29
Application Number : 70848
Regulatory Info : RX
Registration Country : USA
